Characterizing anxiety, pain, sleep, and quality of life among patients in a state Medical Marijuana Program
CONCLUSION: Despite mixed evidence regarding cannabis' efficacy for anxiety, 36.7% of the current sample were certified by a physician for anxiety. Lower QoL was associated with more self-reported comorbid medical conditions, higher total symptom count, and reported use of an opioid and/or benzodiazepine. Future longitudinal data will provide critical information regarding the trajectory of these symptoms and QoL.PMID:35667225 | DOI:10.1016/j.ctcp.2022.101612
Source: Pain Physician - Category: Anesthesiology Authors: Rebecca L Ashare Erin Kelly Emily R Hajjar Swechhya Pant Salimah H Meghani Brooke Worster Source Type: research
More News: Anesthesiology | Anxiety | Chronic Pain | Depression | Pain | Pain Management | Palliative | Palliative Care | Post Traumatic Stress Disorder | Sleep Disorders | Sleep Medicine | Study